Journal of Viral Hepatitis

Papers
(The H4-Index of Journal of Viral Hepatitis is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy55
Ten‐year follow‐up of a randomized controlled clinical trial in chronic hepatitis delta49
Clinical characteristics in patients with SARS‐CoV‐2/HBV co‐infection49
Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis41
Hepatitis E virus genome detection in commercial pork livers and pork meat products in Germany38
COVID‐19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later33
Epidemiological and clinical characteristics of 70 cases of coronavirus disease and concomitant hepatitis B virus infection: A multicentre descriptive study32
Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone30
SARS‐CoV‐2 infection in patients with a normal or abnormal liver29
Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta‐analysis28
The case for simplifying and using absolute targets for viral hepatitis elimination goals27
Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection: A nationwide cohort study27
Altered faecal microbiota on the expression of Th cells responses in the exacerbation of patients with hepatitis E infection26
Loss to follow‐up in the hepatitis C care cascade: A substantial problem but opportunity for micro‐elimination26
Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta‐analysis26
Clinical effects of NTCP‐inhibitor myrcludex B24
Impact of direct‐acting antiviral regimens on mortality and morbidity outcomes in patients with chronic hepatitis c: Systematic review and meta‐analysis24
Risk of hepatocellular carcinoma in hepatitis B and D virus co‐infected patients: A systematic review and meta‐analysis of longitudinal studies23
Mucosal‐associated invariant T‐cells are severely reduced and exhausted in humans with chronic HBV infection23
Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study21
Migratory flow and hepatitis delta infection in Italy: A new challenge at the beginning of the third millennium21
0.15461397171021